{
    "Trade/Device Name(s)": [
        "One Step Multiple Drugs of Abuse Assays",
        "Multiple Drugs of Abuse Assays"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K050024",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020771"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "LDJ",
        "DIO",
        "DJR",
        "DJC",
        "DPK",
        "DJG",
        "LCM",
        "LFG"
    ],
    "Summary Letter Date": "October 2, 2005",
    "Summary Letter Received Date": "October 5, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3620",
        "21 CFR 862.3650",
        "21 CFR 862.3870",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Barbiturate",
        "Benzodiazepine",
        "Cocaine",
        "Marijuana",
        "Methadone",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Opiate",
        "Phencyclidine",
        "Tricyclic antidepressant drugs",
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo One Step Multiple Drugs of Abuse Assays using immunochromatographic lateral flow technology for qualitative detection of drugs in urine",
    "Indications for Use Summary": "Qualitative determination of multiple drugs of abuse in urine to aid in diagnosis and treatment of drug use or overdose, for professional healthcare use",
    "fda_folder": "Toxicology"
}